Literature DB >> 8123899

A novel animal model for investigating persistent airway hyperresponsiveness.

E M Minshall1, M M Riccio, C M Herd, G J Douglas, E A Seeds, M G McKenniff, M Sasaki, D Spina, C P Page.   

Abstract

The present study investigates the development and maintenance of airway hyperresponsiveness in neonatally immunized rabbits. Rabbits were immunized within 24 hr of birth with the antigen Alternaria tenuis together with aluminum hydroxide as an adjuvant, followed by repeated antigen and adjuvant administration up to 3 months of age. Anesthetized, spontaneously breathing rabbits immunized according to this protocol exhibited a 3.7- (p < 0.01) and 1.8-fold (p < 0.05) increase in airway responsiveness to inhaled histamine when compared with groups of naive or sham-immunized rabbits, respectively. In the absence of further antigen challenge, these changes in airway responsiveness to histamine in a subpopulation of antigen-immunized rabbits persisted for up to 12 months of age. This hyperresponsiveness was not associated with an alteration in either total or differential inflammatory cell numbers as assessed by bronchoalveolar lavage (BAL), and no significant differences in isolated bronchial smooth muscle responsiveness to methacholine, histamine, theophylline, or electrical field stimulation were observed. These results demonstrate that neonatal immunization of rabbits with Alternaria tenuis can lead to the development of persistent airway hyperresponsiveness, and that the maintenance of this state is unrelated to either a detectable alteration in cellular infiltration within the airway lumen or changes in bronchial smooth muscle responsiveness. It is suggested that neonatal exposure to antigen and adjuvant may be important determinants for the development of persistent airway hyperresponsiveness. This animal model may provide a useful way to investigate the effects of drugs on airway hyperresponsiveness.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8123899     DOI: 10.1016/1056-8719(93)90015-7

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  9 in total

1.  Characterization of adenosine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits.

Authors:  A el-Hashim; B D'Agostino; M G Matera; C Page
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  The effects of heparin and related molecules on vascular permeability and neutrophil accumulation in rabbit skin.

Authors:  Helen Jones; William Paul; Clive P Page
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

3.  Effects of dexamethasone on airway hyper-responsiveness to the adenosine A1 receptor agonist cyclo-pentyl adenosine in an allergic rabbit model.

Authors:  A Z El-Hashim; K H Banner; W Paul; C P Page
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

4.  Effect of heparin on antigen-induced airway responses and pulmonary leukocyte accumulation in neonatally immunized rabbits.

Authors:  J M Preuss; C P Page
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

5.  Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on antigen-induced airway responses in neonatally immunized rabbits.

Authors:  C M Herd; D Donigi-Gale; T S Shoupe; D A Burroughs; M Yeadon; C P Page
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

6.  Effect of the glucocorticosteroid budesonide and a novel phosphodiesterase type 4 inhibitor CDP840 on antigen-induced airway responses in neonatally immunised rabbits.

Authors:  N Gozzard; A el-Hashim; C M Herd; S M Blake; M Holbrook; B Hughes; G A Higgs; C P Page
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

7.  Effects of theophylline and rolipram on antigen-induced airway responses in neonatally immunized rabbits.

Authors:  N Gozzard; C M Herd; S M Blake; M Holbrook; B Hughes; G A Higgs; C P Page
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

Review 8.  The rabbit as a model for studying lung disease and stem cell therapy.

Authors:  Nurfatin Asyikhin Kamaruzaman; Egi Kardia; Nurulain 'Atikah Kamaldin; Ahmad Zaeri Latahir; Badrul Hisham Yahaya
Journal:  Biomed Res Int       Date:  2013-04-08       Impact factor: 3.411

9.  Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, France.

Authors:  Guillaume Desoubeaux; Janice M Reichert; Matthew Sleeman; Karen L Reckamp; Bernhard Ryffel; Jörg P Adamczewski; Theresa D Sweeney; Rita Vanbever; Patrice Diot; Caroline A Owen; Clive Page; Stéphanie Lerondel; Alain Le Pape; Nathalie Heuze-Vourc'h
Journal:  MAbs       Date:  2016-06-06       Impact factor: 5.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.